Tim Kong

SMARCA4 loss is synthetic lethal with CDK4/6 inhibition in non-small cell lung cancer

Yibo Xue, Brian Meehan, Zheng Qing Fu et al. · Nature Communications · 2019 · 182 citations · Full text

CD44 Promotes PD-L1 Expression and Its Tumor-Intrinsic Function in Breast and Lung Cancers

Tim Kong, Ryuhjin Ahn, Kangning Yang et al. · Cancer Research · 2019 · 154 citations · Full text

CDK4/6 inhibitors target SMARCA4-determined cyclin D1 deficiency in hypercalcemic small cell carcinoma of the ovary

Yibo Xue, Brian Meehan, Elizabeth A. Macdonald et al. · Nature Communications · 2019 · 110 citations · Full text

Pacritinib is a potent ACVR1 inhibitor with significant anemia benefit in patients with myelofibrosis

Stephen T. Oh, Ruben A. Mesa, Claire Harrison et al. · Blood Advances · 2023 · 60 citations · Full text

Antifibrotic Therapy, Immunology, Cardiovascular Pharmacology +17

Direct Binding between Pre-S1 and TRP-like Domains in TRPP Channels Mediates Gating and Functional Regulation by PIP2

Wang Zheng, Ruiqi Cai, Laura Hofmann et al. · Cell Reports · 2018 · 48 citations · Full text